Metropolitan Digital

Men's Weekly


.

How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers

  • Written by Dalindyebo Shabalala, Associate Professor, University of Dayton
How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakersHospital staff in Lagos, Nigeria, administer the AstraZeneca vaccine.AP Photo/Sunday Alamba

The world has a COVID-19 vaccine access problem: Almost half of all doses administered so far have been in Europe and North America, while many poorer countries have vaccinated less than than 1% of their populations.

With new coronavirus variants raising the...

Read more: How to get COVID-19 vaccines to poor countries – and still keep patent benefits for drugmakers

More Articles ...

  1. Colombia gives nearly 1 million Venezuelan migrants legal status and right to work
  2. COVID-19 public health messages have been all over the place – but researchers know how to do better
  3. Trump, defying custom, hasn't given the National Archives records of his speeches at political rallies
  4. Compassionate courage moves beyond 'cancel culture' to challenge systemic racism – but it's hard work
  5. 'Deprogramming' QAnon followers ignores free will and why they adopted the beliefs in the first place
  6. Is magic immoral? It played a role in the development of early Christianity
  7. Plants thrive in a complex world by communicating, sharing resources and transforming their environments
  8. Knoxville school shooting serves as stark reminder of a familiar – but preventable – threat
  9. US postpones Afghanistan troop withdrawal in hopes of sustaining peace process: 5 essential reads
  10. The EU wants a carbon tax on imports – but would it be the climate solution officials expect?
Metropolitan republishes selected articles from The Conversation USA with permission

Visit The Conversation to see more